49 related articles for article (PubMed ID: 17173892)
1. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
2. Montelukast Ameliorates 2K1C-Hypertension Induced Endothelial Dysfunction and Associated Vascular Dementia.
Gupta S; Singh P; Sharma B
Curr Hypertens Rev; 2024; 20(1):23-35. PubMed ID: 38192137
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells.
Suknuntha K; Yubolphan R; Krueaprasertkul K; Srihirun S; Sibmooh N; Vivithanaporn P
Asian Pac J Cancer Prev; 2018 Mar; 19(3):833-837. PubMed ID: 29582642
[TBL] [Abstract][Full Text] [Related]
4. The renoprotective potential of montelukast: a scoping review.
Sarmadian R; Gilani A; Mehrtabar S; Mahrokhi Koushemehr S; Hakimzadeh Z; Yousefichaijan P
Ann Med Surg (Lond); 2024 Jun; 86(6):3568-3576. PubMed ID: 38846849
[TBL] [Abstract][Full Text] [Related]
5. A novel model of urosepsis in rats developed by injection of Escherichia coli into the renal pelvis.
Cao Y; Bai C; Si P; Yan X; Zhang P; Yisha Z; Lu P; Tuoheti K; Guo L; Chen Z; Bai X; Liu T
Front Immunol; 2022; 13():1074488. PubMed ID: 36685507
[TBL] [Abstract][Full Text] [Related]
6. Montelukast Influence on Lung in Experimental Diabetes.
Gales C; Stoica B; Rusu-Zota G; Nechifor M
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792932
[No Abstract] [Full Text] [Related]
7. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats.
Hagar HH; Alhazmi SM; Arafah M; Bayoumy NM
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial.
El-Khateeb E; El-Berri EI; Mosalam EM; Nooh MZ; Abdelsattar S; Alghamdi AM; Alrubia S; Abdallah MS
Front Pharmacol; 2023; 14():1153653. PubMed ID: 37113754
[No Abstract] [Full Text] [Related]
9. Leukotrienes vs. Montelukast-Activity, Metabolism, and Toxicity Hints for Repurposing.
Marques CF; Marques MM; Justino GC
Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145259
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic and protective effects of montelukast against doxorubicin-induced acute kidney damage in rats.
Köse E; Oğuz F; Vardi N; Ediz Sarihan M; Beytur A; Yücel A; Polat A; Eki Nci N
Iran J Basic Med Sci; 2019 Apr; 22(4):407-411. PubMed ID: 31168345
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol and Montelukast Alleviate Paraquat-Induced Hepatic Injury in Mice: Modulation of Oxidative Stress, Inflammation, and Apoptosis.
El-Boghdady NA; Abdeltawab NF; Nooh MM
Oxid Med Cell Longev; 2017; 2017():9396425. PubMed ID: 29201275
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroids for renal scar prevention in children with acute pyelonephritis.
Sakulchit T; Goldman RD
Can Fam Physician; 2017 Apr; 63(4):286-287. PubMed ID: 28404702
[No Abstract] [Full Text] [Related]
13. Use of antioxidants in urinary tract infection.
Allameh Z; Salamzadeh J
J Res Pharm Pract; 2016; 5(2):79-85. PubMed ID: 27162800
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Montelukast on Liver Damage in an Experimental Obstructive Jaundice Model.
Kuru S; Kismet K; Barlas AM; Tuncal S; Celepli P; Surer H; Ogus E; Ertas E
Viszeralmedizin; 2015 Apr; 31(2):131-8. PubMed ID: 26989383
[TBL] [Abstract][Full Text] [Related]
15. Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis.
Bahat Özdoğan E; Özdemir T; Arslansoyu Çamlar S; Imamoğlu M; Cobanoğlu Ü; Sönmez B; Tosun İ; Doğan I
Biomed Res Int; 2014; 2014():134940. PubMed ID: 25105116
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Abdel-Raheem IT; Khedr NF
Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
[TBL] [Abstract][Full Text] [Related]
17. Effects of Montelukast on free radical production in whole blood and isolated human polymorphonuclear neutrophils (PMNs) in asthmatic children.
Al Saadi MM; Meo SA; Mustafa A; Shafi A; Tuwajri AS
Saudi Pharm J; 2011 Oct; 19(4):215-20. PubMed ID: 23960762
[TBL] [Abstract][Full Text] [Related]
18. Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.
Malekinejad H; Nikibakhsh A; Gholizadeh-Soltani S; Farshid A
Indian J Nephrol; 2012 Jan; 22(1):26-32. PubMed ID: 22279339
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
